Government & Community Relations
Drug
Cost Reimbursement
Pharmacare coverage of new treatments for MS is of primary importance to persons living with MS. We believe in the principles of equity, affordability and quality when it comes to a comprehensive drug program. The following are some recent written examples of our initiatives done on this front:
Manitoba invests in MS Support & Research - October 2010
For
more information contact:
Darell Hominuk
Director, Client Services and Government Relations
darell.hominuk@mssociety.ca
 |
